Calmodulin (CaM) inhibits the skeletal muscle ryanodine receptor-1 (RyR1) and cardiac muscle RyR2 at micromolar Ca 2؉ but activates RyR1 and inhibits RyR2 at submicromolar Ca 2؉ by binding to a single, highly conserved CaM-binding site. To identify regions responsible for the differential regulation of RyR1 and RyR2 by CaM, we generated chimeras encompassing and flanking the CaM-binding domain. We found that the ex- (8, 9) and purified RyR1 and RyR2 (10) showed that the two receptor isoforms bind one molecule of CaM per RyR subunit in the absence and presence of Ca 2ϩ . CaM protection of trypsin digestion of RyR1 (11) and site-directed mutagenesis of RyR1 (12) and RyR2 (13) demonstrated that the two RyRs have a single CaM regulatory binding domain (CaMBD) (aa 3614 -3643 in RyR1) for the Ca 2ϩ -free and Ca 2ϩ -bound (Ca 2ϩ -CaM) forms of CaM. The CaM-binding domain is highly conserved among the mammalian isoforms, yet corresponding mutations in the RyR1 and RyR2 CaM-binding domain resulted in a different response to CaM in 35 S-CaM binding and functional measurements (13). This result suggests that other isoform-specific regions are responsible for the differential modulation of RyR1 and RyR2 by CaM.To test the hypothesis of an involvement of isoform-specific regions in regulating RyR1 and RyR2 by CaM, we constructed a series of RyR1/RyR2 chimeras and determined their CaMbinding properties and modulation by CaM. The results suggest that multiple regions are involved in transducing the functional effects of CaM in RyR1 and RyR2. The present study focused on the role of one of these regions. We found that substitution of five amino acid residues in RyR2 with those of RyR1 eliminated CaM inhibition but not CaM binding at [Ca 2ϩ ] Ͻ 1 M.